YTTRIUM Y-90 EPRATUZUMAB TETRAXETAN
UNII J36232195E

Substance Identification & Data

This profile provides standardized clinical and technical data for Yttrium Y-90 Epratuzumab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J36232195E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 501423-25-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J36232195E

CAS Registry Number

501423-25-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

YTTRIUM Y-90 EPRATUZUMAB TETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2582

National Cancer Institute reference terminology for clinical and research data.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Yttrium Y-90 Epratuzumab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.